AstraZeneca PLC (NYSE:AZN)
| 47.68 Delayed Data As of Dec 06 |  +0.06 / +0.13%Today’s Change | 35.30 Today|||52-Week Range 49.22 | +25.54% Year-to-Date |
Latest AZN News | Press Releases
| Is Clovis Oncology Really a Buyout Candidate? Dec 03 / MotleyFool.com - Paid Partner Content | Here's Why Lexicon Pharmaceuticals Is Tumbling Today Dec 02 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 47.62 |
| Today’s open | 47.73 |
| Day’s range | 47.56 - 47.78 |
| Volume | 2,477,503 |
| Average volume (3 months) | 3,174,768 |
| Market cap | $125.1B |
Data as of 6:30pm ET, 12/06/2019
Growth & Valuation
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +3.72% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 59.4 |
| Price/Sales | 4.36 |
| Price/Book | 9.69 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.26 | +0.30% |
| LLYEli Lilly and Co | -0.13 | -0.11% |
| SNYSanofi | -0.05 | -0.11% |
| GSKGlaxoSmithKline | +0.30 | +0.66% |
Data as of 6:30pm ET, 12/06/2019
Financials
| Next reporting date | February 14, 2020 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
